Short answer · Medically reviewed summary · Last updated: 2026-05-08
Anencephaly is a severe neural tube defect resulting from the incomplete development of the brain, skull, and scalp, and currently, there are no medical interventions or surgical procedures that can reverse or cure the condition. Research is primarily focused on primary prevention through folic acid supplementation and understanding the complex genetic and environmental interactions that cause anencephaly to occur during early embryonic development. What are the current research directions for anencephaly? Modern research into anencephaly is largely centered on prenatal prevention rather than postnatal treatment.
1 people with Anencephaly have shared their first-person experience on this question at DiseaseMaps.
What are the latest advances in Anencephaly?
Latest advances in Anencephaly: recent research, treatments in development and what they could mean, with sources.
Anencephaly is a severe neural tube defect resulting from the incomplete development of the brain, skull, and scalp, and currently, there are no medical interventions or surgical procedures that can reverse or cure the condition. Research is primarily focused on primary prevention through folic acid supplementation and understanding the complex genetic and environmental interactions that cause anencephaly to occur during early embryonic development.
What are the current research directions for anencephaly?
Modern research into anencephaly is largely centered on prenatal prevention rather than postnatal treatment. Because the neural tube closes within the first 28 days of pregnancy, scientists are studying how maternal nutritional status, specifically folate metabolism, influences the risk of anencephaly. Researchers are also investigating the role of specific genes involved in neural tube closure, such as those within the Wnt signaling pathway, to provide better genetic counseling for families.
Are there new diagnostic or screening tools for anencephaly?
Advances in diagnostic technology have significantly improved the early detection of anencephaly. High-resolution maternal serum alpha-fetoprotein (MSAFP) screening and detailed fetal ultrasounds, typically performed between 11 and 14 weeks of gestation, allow for earlier diagnosis. Recent studies are exploring the utility of cell-free fetal DNA testing and advanced maternal blood biomarkers to detect neural tube defects earlier in the first trimester.
What is the status of clinical trials and treatments?
Currently, there are no curative clinical trials for anencephaly, as the condition involves the absence of major portions of the brain. While research is ongoing, the focus remains on:
- Large-scale public health initiatives to increase folic acid fortification in global food supplies.
- Genetic studies identifying variants that may increase recurrence risks for future pregnancies.
- Supportive care research aimed at improving palliative care outcomes for affected infants and their families.
Next steps
- Consult a genetic counselor to discuss recurrence risks and preconception health if planning future pregnancies.
- Connect with the 31 members of the anencephaly community at DiseaseMaps.org for support and shared experiences.
- Visit ClinicalTrials.gov to monitor research regarding neural tube defect prevention studies.
- Discuss high-dose folic acid supplementation protocols with an obstetrician if you are at high risk.
Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the guidance of a qualified healthcare provider regarding a medical condition.
References
- NIH Genetic and Rare Diseases Information Center (GARD): Anencephaly
- Orphanet: Neural tube defects and related malformations
- Centers for Disease Control and Prevention (CDC): Facts about Anencephaly
- OMIM (Online Mendelian Inheritance in Man): Neural Tube Defects
Anencephaly Psychological Impact
We conducted a project to examine the
relationship between pregnancy
management choices and psychological
distress following the loss of a baby to
anencephaly. Men and women who
previously lost a baby to anencephaly
completed questionnaires to collect
information about their pregnancy and to
assess levels of grief, post-traumatic stress
and depression.
Individual experiences varied greatly but
several patterns were observed:
Women experienced more psychological
distress than men.
Psychological distress tended to decrease
over time.
Increased participation in organizational
religious activities, such as attending
church, resulted in less grief in both
women and men.
Pregnancy continuation resulted in less
despair, avoidance and depression in
women (this was not true for men).
Pregnancy termination early in
pregnancy resulted in less psychological
distress than pregnancy termination
later in pregnancy, especially for men.
Ultimately, coping with the loss of a baby is
deeply personal and will be experienced
differently by each person. We recommend
health care providers discuss the risks and
benefits of all options, but allow the family
to make decisions that are best for them.
Cope H. et al (2015) Pregnancy continuation and
organizational religious activity following prenatal
diagnosis of a lethal fetal defect are associated with
improved psychological outcome. Prenatal Diagnosis,
35: 761-768.
Posted Aug 16, 2017 by Lisa 1685
